6 Meridian Increases Stock Position in Danaher Co. (NYSE:DHR)

6 Meridian boosted its stake in Danaher Co. (NYSE:DHR) by 1.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 48,598 shares of the conglomerate’s stock after purchasing an additional 803 shares during the quarter. 6 Meridian’s holdings in Danaher were worth $7,459,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently made changes to their positions in the company. Nuveen Asset Management LLC raised its stake in shares of Danaher by 10,853.5% during the second quarter. Nuveen Asset Management LLC now owns 3,664,924 shares of the conglomerate’s stock worth $523,790,000 after acquiring an additional 3,631,465 shares in the last quarter. Vanguard Group Inc. raised its stake in shares of Danaher by 1.4% during the second quarter. Vanguard Group Inc. now owns 48,262,218 shares of the conglomerate’s stock worth $6,897,635,000 after acquiring an additional 686,421 shares in the last quarter. California Public Employees Retirement System raised its stake in shares of Danaher by 16.6% during the third quarter. California Public Employees Retirement System now owns 2,575,783 shares of the conglomerate’s stock worth $372,020,000 after acquiring an additional 365,772 shares in the last quarter. Schroder Investment Management Group raised its stake in shares of Danaher by 16.9% during the second quarter. Schroder Investment Management Group now owns 2,518,155 shares of the conglomerate’s stock worth $359,895,000 after acquiring an additional 363,465 shares in the last quarter. Finally, SG Americas Securities LLC raised its stake in shares of Danaher by 179.3% during the third quarter. SG Americas Securities LLC now owns 561,470 shares of the conglomerate’s stock worth $81,093,000 after acquiring an additional 360,427 shares in the last quarter. 77.99% of the stock is currently owned by institutional investors and hedge funds.

Shares of Danaher stock opened at $159.57 on Tuesday. The company has a debt-to-equity ratio of 0.52, a quick ratio of 3.09 and a current ratio of 3.43. Danaher Co. has a 52-week low of $103.98 and a 52-week high of $159.75. The stock has a market capitalization of $113.57 billion, a price-to-earnings ratio of 35.30, a P/E/G ratio of 2.48 and a beta of 0.93. The company’s 50 day moving average price is $151.28 and its 200-day moving average price is $143.07.

Danaher (NYSE:DHR) last issued its earnings results on Thursday, October 24th. The conglomerate reported $1.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.15 by $0.01. Danaher had a net margin of 12.13% and a return on equity of 11.42%. The firm had revenue of $5.04 billion for the quarter, compared to analysts’ expectations of $5.02 billion. During the same quarter last year, the business earned $1.10 earnings per share. The business’s revenue was up 3.8% on a year-over-year basis. As a group, equities research analysts forecast that Danaher Co. will post 4.74 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Friday, December 27th will be issued a $0.17 dividend. This represents a $0.68 annualized dividend and a dividend yield of 0.43%. The ex-dividend date of this dividend is Thursday, December 26th. Danaher’s dividend payout ratio is 15.04%.

Several research analysts have commented on the stock. Stifel Nicolaus reissued a “hold” rating and set a $150.00 price target on shares of Danaher in a research note on Thursday, November 14th. Needham & Company LLC lifted their price target on shares of Danaher from $152.00 to $167.00 and gave the stock a “buy” rating in a research note on Thursday, January 2nd. ValuEngine downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. Citigroup assumed coverage on shares of Danaher in a research note on Monday, January 6th. They set a “buy” rating and a $180.00 price target on the stock. Finally, Wells Fargo & Co assumed coverage on shares of Danaher in a research note on Tuesday, January 7th. They set an “overweight” rating and a $170.00 price target on the stock. Six research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of $158.38.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

Further Reading: What is the outlook for the FAANG stocks?

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.